SMRTR summary
GLP-1 drugs like tirzepatide cause muscle loss alongside fat loss, but experimental antibody apitegromab halved this effect in a 102-person trial. Whether preserving muscle improves long-term health outcomes remains unclear.
SMRTR provides this summary for quick context. The original article belongs to Reddit.
Read the original articleThis archive is built from SMRTR newsletter summaries. Subscribe for hand-picked stories without the extra noise.
More SMRTR summaries that connect to this topic.
The Salk Institute's study identified BCL6 protein as vital for maintaining muscle mass. Mice without BCL6 had 40% less muscle mass and weaker muscles, while increasing BCL6...
Syntis Bio's new drug demonstrated 1% weekly weight loss in rats over six weeks without muscle loss, and a small human study found it safe with potential metabolic benefits,...
Two biotech companies are developing gene therapies that could reprogram body cells to produce GLP-1 hormones naturally, potentially replacing weekly weight-loss injections like...
Chinese pharmaceutical companies are developing innovative obesity drugs, including ecnoglutide, which outperformed placebo in clinical trials. Participants lost up to 13.8 kg...
Researchers found that people with more muscle mass and less visceral fat have younger-looking brains on MRI scans. Building muscle while reducing deep belly fat may help maintain...
Scientists discovered Ozempic-like drugs may reverse biological aging by up to three years, according to new research from TruDiagnostic lab. In a 32-week study involving HIV...